Reports 2 Jul 2025
Artificial intelligence and the future of antibody discovery
Discover how AI and ML are already shaping therapeutic antibody discovery and explore their future potential.
About
Born in Chicago, I grew up close to Frankfurt, Germany. I hold an MSc in Neuroscience from University College London and a BA in Biochemistry from Knox College in the US.
Outside of science-related activities, I enjoy skiing and writing music.
Articles by Alexander Burik
Reports 25 Sep 2024
Current trends & innovations in 3D organoids
Discover how 3D organoids are already shaping research & drug development today and explore their future potential.
Accelerating the path to clinical filing applications with rapid toxicology material delivery
Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.
The crucial role of GS-CHO innovation in biopharmaceutical progress
Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins.
Large molecule manufacturing: addressing challenges with strategies for success
Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success.
More sustainable drug development and lab sustainability
From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!
ADVERTISEMENT
ADVERTISEMENT
Expert Advice 20 Mar 2023
Nine tips to succeed in pharma-biotech partnerships
The question of whether to partner with another company is critical to the long-term development of a biotech. Nonetheless, it can be easy for a small company to underestimate the resources it needs to put into a successful collaboration. Here, we’ll go over some expert advice on what to do and what not to do […]
Streamlining CAR-T cell therapy manufacturing: a platform approach
Chimeric antigen receptor-T cell (CAR-T) therapy is an exciting treatment modality for blood cancers that do not respond to standard treatment. But manufacturing these CAR-T therapies brings challenges. How can life science companies overcome them to minimize costs and improve patient access? In patients with cancer for whom chemotherapy proves unsuccessful, CAR-T therapy may provide […]
Navigating cell and gene therapy manufacturing with a long-term partnership
Cell and gene therapies have proven to be promising treatments for cancers and genetic diseases, but developers face key challenges before these treatments reach patients’ bedsides. A long-term partnership with a contract development and manufacturing organization (CDMO) can ease the path life science companies travel from manufacturing these life-changing treatments and bringing them to the […]
Artificial Intelligence: A Road to Faster and Better Drug Discovery?
Artificial intelligence (AI) has become a part of everyday modern life and continues to generate excitement. In this article, we will take a look at how biotechs are advancing into AI-facilitated early drug design, its real-world outcomes so far, and whether it is living up to its potential in the life science industry. AI enables […]
News and Trends 21 Nov 2019
Update: Swedish Medical Device Fails to Treat Spinal Cord Injury
Update (21/11/2019): The Swedish biotech BioArctic has terminated the clinical development of a biodegradable implant that is designed to treat spinal cord injury by encouraging the regrowth of nerve cells. The decision was made when an interim analysis in BioArctic’s phase I/II trial concluded that the treatment was ineffective. BioArctic will instead focus on developing […]
News and Trends 27 Sep 2018
Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward
Update (27/09/2018): New investment from Dutch venture capital fund Innovation Industries brings A-Mansia’s Series A round up to €18M. The company’s first human study of the effects of A. muciniphila in volunteers is currently underway at the University of Louvain. Published on 27/04/2018 A-Mansia Biotech has raised €13M in Series A financing led by Seventure Partners. The […]
ADVERTISEMENT
